Study: PET could aid in measuring Huntington's disease progression

08/30/2013 | · (free registration)

A study in The Journal of Clinical Investigation suggests that PET scans can be used to effectively track Huntington's disease progression and could aid in evaluating novel drugs for neurodegenerative disorders before symptoms appear. U.S. researchers said they were able to detect abnormalities in the brains of 12 asymptomatic patients who carry the Huntington's disease gene after subjecting them to a series of PET scans over seven years.

View Full Article in: · (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI